Navigation Links
United Therapeutics Corporation Reports Second Quarter 2011 Financial Results


609—Share-based compensation

(27,037)(574)Earnings before non-cash charges



65,686Earnings before non-cash charges per share:Basic






1.09Weighted average number of common shares outstanding:Basic


62,75660,393Conference CallWe will host a half-hour teleconference on Thursday, July 28, 2011, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533. A rebroadcast of the teleconference will be available for one week by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291 and using access code 80689472.

This teleconference is also being webcast and can be accessed via our website at

About United TherapeuticsUnited Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.

Non-GAAP Financial InformationThis press release contains a financial measure, earnings before non-cash charges, that does not comply with United States generally accepted accounting principles (GAAP). This measure supplements our financial results prepared in accordance with GAAP as reported below.

We use earnings before non-cash charges to assist us in: (1) planning, including the preparation of our annual operating budget; (2) allocating resources to enhance the financial performance of our business; (3) evaluating the effectiveness of our operational strategies; and (4) evaluating our capacity to fund capital expenditures and expand our business. We believe this non-GAAP financial measure enhances investors' understanding of our financial results by excluding certain expenses that w

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
2. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
3. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
4. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
5. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
6. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
7. United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
8. United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
9. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
10. United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
11. Report Details How States Respond to Citizens United Decision
Post Your Comments:
(Date:10/8/2015)... 2015  Today the Wyss Institute for Biologically Inspired ... start-up company Opsonix Inc. The announcement follows ... of Technology Development (OTD) and Opsonix Inc. enabling ... clinical use. --> ... people every year in the U.S. — more than ...
(Date:10/8/2015)... , ... October 08, 2015 , ... ... the cystic fibrosis transmembrane conductance regulator (CFTR) gene and results in dysfunction of ... sticky mucus accumulates in the lungs. This mucus is very difficult to clear, ...
(Date:10/7/2015)... ... October 07, 2015 , ... The Riordan-McKenna ... a public educational seminar on the latest advances in adult stem cell therapy ... – 3:00 pm at the Hilton Dallas/Southlake Town Square in Southlake, Texas. , ...
(Date:10/7/2015)... , Oct. 7, 2015  October is National Liver ... has committed to donating a portion of its October ... and hepatology practices. ... in a variety of ways; whether it is by ... world, collaborating with researchers in different disease and investigation ...
Breaking Biology Technology:
... Advances in Vaccine Research may Lead to Improved Vaccine ... Leading Cause of Death in Developing Countries, LYON, ... the sanofi-aventis Group, announced today that it has,signed a ... of Denmark (SSI) for the development and marketing of ...
... developing the perfect complement to the power tie: a ... electronic devices for soldiers in the field, hikers and ... to electrical energy. , The February 14 issue of ... covered with zinc oxide nanowires can generate electrical current ...
... of Common Stock in Exchange, for Senior Subordinated and Subordinated ... ... interest, SEATTLE, Feb. 13 Cell Therapeutics, Inc.,("CTI" or the "Company") ... aggregate principal of its outstanding 5.75%,Convertible Senior Subordinated Notes due 2008 (the ...
Cached Biology Technology:
(Date:9/28/2015)... YORK , Sept. 28, 2015 /PRNewswire/ ... announced today that its expedited traveler service ... innovative platform transforms travel, bringing a frictionless ... its members. "CLEAR offers our ... enhances customer service," said Jim Smith ...
(Date:9/28/2015)... 28, 2015 The global ... USD 12.03 billion by 2020, growing at a CAGR ... as Backside Illumination (BSI) technique to improve picture quality ... period.      (Logo: , ... to reduce loss and, thus, reduce the noise interference ...
(Date:9/28/2015)... , Sept. 28, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced that Lenovo has selected Synaptics , ... FS4202, for its latest smartphone, the Vibe P1. The ... to unlock the device and provide swift access to ... The feature-rich Natural ID FS4202 sensor solution utilizes AES256-bit ...
Breaking Biology News(10 mins):
... mothers-to-be have a remarkable way to protect their unborn ... can cause miscarriage and reactivate the ovulatory cycle, pregnant ... blocking their smell. Researchers from the European Molecular Biology ... nature of this ability. A surge of the chemical ...
... Biology (ASBMB) has announced the recipients of its ... for their outstanding achievements and contributions to science. ... Experimental Biology 2009 Meeting, April 18-22, in New ... NIDDK, National Institutes of Health, will give the ...
... Neurological experts from across the U.S. and other ... Medical Center will discuss the latest findings in basic ... International Fragile X Conference, to be held July 23-27 ... diagnosed with Fragile X also will be attending the ...
Cached Biology News:
Request Info...
... system. For real-time or pre-programmed liquid ... or general liquid-handling research applications. >UL> ... Run experiments automatically - even ... flexibility Turnkey perfusion system includes ...
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
Concentration: 1mg/ml. Antigen: Propidium Iodide ...
Biology Products: